Quality of life results for accelerated partial breast irradiation with interstitial brachytherapy versus whole breast irradiation in early breast cancer after breast …

Rebekka Schäfer,Vratislav Strnad,Csaba Polgár,Wolfgang Uter,Guido Hildebrandt,Oliver J Ott, Daniela Kauer-Dorner, Hellen Knauerhase,Tibor Major, Jaroslaw Lyczek,Jose Luis Guinot,Jürgen Dunst, Cristina Gutierrez Miguelez,Pavel Slampa,Michael Allgäuer,Kristina Lössl,György Kovács, Arnt-René Fischedick,Rainer Fietkau,Alexandra Resch,Anna Kulik, Leo Arribas,Peter Niehoff,Ferran Guedea, Annika Schlamann,Christine Gall,Bülent Polat, Thomas G Wendt, Marion Hindemith,Richard Pötter, Martina Malzer

The lancet oncology(2018)

引用 48|浏览4
暂无评分
摘要
BackgroundPrevious results from the GEC-ESTRO trial showed that accelerated partial breast irradiation (APBI) using multicatheter brachytherapy in the treatment of early breast cancer after breast-conserving surgery was non-inferior to whole-breast irradiation in terms of local control and overall survival. Here, we present 5-year results of patient-reported quality of life.MethodsWe did this randomised controlled phase 3 trial at 16 hospitals and medical centres in seven European countries. Patients aged 40 years or older with 0–IIA breast cancer were randomly assigned (1:1) after breast-conserving surgery (resection margins ≥2 mm) to receive either whole-breast irradiation of 50 Gy with a boost of 10 Gy or APBI using multicatheter brachytherapy. Randomisation was stratified by study centre, tumour type, and menopausal status, with a block size of ten and an automated dynamic algorithm. There was no masking …
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要